It is time to act and no time to waste. That is the urgent message of the report "The Looming Co-epidemic of TB-Diabetes: A Call to Action" launched jointly by the International Union Against Tuberculosis and Lung Disease (The Union) and the World Diabetes Foundation (WDF) at the opening day of the 45th Union World Conference on Lung Health in Barcelona. The report warns against the brewing storm of diabetes and tuberculosis (TB) that is no longer confined to the teacup.
29 October 2014 | Citizen News Service
The report, The Looming Co-epidemic of TB Diabetes: A Call to Action (1), launched on the opening day of the 45th Union World Conference on Lung Health currently taking place in Barcelona, Spain October 28 - November 1, synthesizes evidence from the medical and scientific literature, promotes an international policy framework for action, and lays out a new research agenda to fill knowledge gaps. The report challenges the conventional approach to health policymaking, which has historically addressed infectious diseases and noncommunicable (or “chronic”) diseases independently.
29 October 2014 | International Union Against Tuberculosis and Lung Disease
As effective treatments for HIV become more widely available in low-income and middle-income countries, there's an urgent need to assess and manage health risks in the growing number of people living with HIV. An update on non-communicable diseases among HIV-positive populations in low-income and middle-income countries appears as a supplement to in JAIDS: Journal of Acquired Immune Deficiency Syndromes. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
14 August 2014 | Eurekalert Medicine & Health
One of the most feared diseases in the world is now, for British doctors, a manageable chronic condition. It’s a triumph we’re oddly scared to talk about
17 April 2014 | The Spectator
This issue of Research Initiative, Treatment Action (RITA!) carefully examines evidence from well over 100 studies on cardiovascular risk factors and the impact of individual and combined antiretrovirals on the heart.This RITA! also features an interview with the University of Wisconsin’s James Stein, perhaps the leading authority on cardiovascular disease in people with HIV. Stein offers frank and insightful answers to questions on cardiovascular risk, screening adults and children, the Framingham score, lipid targets, aspirin prophylaxis, and smoking.
20 June 2013 | RITA! / Center for AIDS Information and Advocacy
Government's annual death report has confirmed the trend that less South Africans have been dying of HIV/AIDS-related diseases. However, more people are dying of non-communicable diseases such as diabetes. ...
11 April 2013 | AllAfrica.com
Researchers at the University of Virginia School of Medicine have determined the molecular structure of a protein whose mutations have been linked to several early aging diseases, and to side effects of common HIV and AIDS medications.
11 April 2013 | University of Virginia press release
Every year of treatment with lipid-lowering statins boosted the risk of diabetes 10% in members of the HIV Outpatient Study (HOPS). The results confirm an earlier finding of self-reported diabetes associated with statin use in a large general-population study of US postmenopausal women, but the impact of statins seemed more modest in the HOPS analysis.
07 March 2013 | EATG / NATAP
A model developed by the Data Collection on Adverse events of Anti-HIV Drugs (D:A:D) study group proved a good predictor of diabetes in HIV-positive people, better than the Framingham model in certain circumstances.
09 November 2012 | International AIDS Society
The bulk of the £9.8bn the NHS spends on diabetes each year is wasted - and the disease could cost it a sixth of its entire budget by 2035, says a report.
25 April 2012 | BBC Health